| About the author: |
V. V. Petrushenko, D. I. Grebeniuk, K. L. Lonskii, V. Y. Gladkykh, O. O. Kedyk, L. H. Rosha |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
The study analyzed the effectiveness of L-Ornithine L-Aspartate in patients with esophageal variceal bleeding. The study included 67 patients with a confirmed diagnosis of liver cirrhosis complicated by portal bleeding. The experimental group consisted of patients who, in addition to complex treatment in order to maintain liver function, were prescribed intravenous L-Ornithine L-Aspartate with subsequent change to oral administration. The comparison group included patients who did not receive this drug. To assess the effectiveness of treatment, general clinical indices, biochemical indices of the functional state of the liver, indices of quality of life were studied. The use of this drug made it possible to shorten the length of hospital stay and significantly faster improve the main clinical and laboratory indices of the functional state of the liver and the quality of life of patients. |
| Tags |
L-Ornithine L-Aspartate, liver cirrhosis, esophageal variceal bleeding, quality of life |
| Bibliography |
- Brunner F, Berzigotti A, Bosch J. Prevention and treatment of variceal haemorrhage in 2017. Liver Int. 2017 Jan;37 Suppl 1:104–115. doi: 10.1111/liv.13277. Review. PubMed PMID: 28052623.
- Buechter M, Kahraman A, Manka P, Gerken G, Jochum C, Canbay A, Dechêne A. Spleen and Liver Stiffness Is Positively Correlated with the Risk of Esophageal Variceal Bleeding. Digestion. 2016;94(3):138–144. doi: 10.1159/000450704. Epub 2016 Oct 19. PubMed PMID: 27756066.
- Butterworth RF, Canbay A. Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease. Dig Dis. 2019; 37(1):63–68. doi: 10.1159/000491429. Epub 2018 Jul 17. PMID: 30016770; PMCID: PMC6390461.
- Butterworth RF, McPhail MJW. L-Ornithine L-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses. Drugs. 2019 Jan 31. doi: 10.1007/s40265-018-1024-1. [Epub ahead of print] Review. PubMed PMID: 30706425.
- Goh ET, Stokes CS, Sidhu SS, Vilstrup H, Gluud LL, Morgan MY. L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev. 2018 May 15;5:CD012410. doi: 10.1002/14651858.CD012410.pub2. Review. PubMed PMID: 29762873.
- Gross M. [Liver cirrhosis and the most common complications: diagnosis and treatment]. MMW Fortschr Med. 2015 Mar 26;157 Suppl 1:75–9. doi: 10.1007/s15006-015-2550-3. Review. German. PubMed PMID: 26012993.
- Hernández-Gea V, Berbel C, Baiges A, García-Pagán JC. Acute variceal bleeding: risk stratification and management (including TIPS). Hepatol Int. 2018 Feb; 12(Suppl 1):81–90. doi: 10.1007/s12072-017-9804-3. Epub 2017 Jun 20. Review. PubMed PMID: 28634688.
- Higuera-de-la-Tijera F, Servín-Caamaño AI, Salas-Gordillo F, Pérez-Hernández JL, Abdo-Francis JM, Camacho-Aguilera J, Alla SN, Jiménez-Ponce F. Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding. Can J Gastroenterol Hepatol. 2018 Jul 10;2018:3015891. doi: 10.1155/2018/3015891. PMID: 30079329; PMCID: PMC6069577.
- Moctezuma Velázquez C, Abraldes JG. Non-invasive diagnosis of esophageal varices after Baveno VI. Turk J Gastroenterol. 2017 May;28(3):159–165. doi: 10.5152/tjg.2017.16744. Review. PubMed PMID: 28492370.
- Petrushenko VV, Hrebeniuk DI, Radoha YV, Tsyhalko DV, Melnychuk MO, Dorozhynskyi YA, Tatarin AY. Prevention of bleeding in patients with portal hypertension syndrome. Medicni perspektivi. 2018; 23(4):164–165.
- Sidhu SS, Sharma BC, Goyal O, Kishore H, Kaur N. L-ornithine L-aspartate in bouts of overt hepatic encephalopathy. Hepatology. 2017 Jul 27. doi: 10.1002/hep.29410. [Epub ahead of print] PubMed PMID: 28749571.
- Tayyem O, Bilal M, Samuel R, Merwat SK. Evaluation and management of variceal bleeding. Dis Mon. 2018 Jul; 64(7):312–320. doi: 10.1016/j.disamonth.2018.02.001. Epub 2018 Mar 7. Review. PubMed PMID: 29525376.
- Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014 May 17; 383(9930):1749–61. doi: 10.1016/S0140-6736(14)60121-5. Epub 2014 Jan 28. Review. PubMed PMID: 24480518.
- Zhou WC, Zhang QB, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol. 2014 Jun 21;20(23):7312–24. doi: 10.3748/wjg.v20.i23.7312. Review. PubMed PMID: 24966602; PubMed Central PMCID: PMC4064077.
|
| Publication of the article |
«World of Medicine and Biology» №2(76), 2021 year, 112-117 pages, index UDK 616.149 – 008.341.1: 347.440.32 |
| DOI |
10.26724/2079-8334-2021-2-76-112-117 |
